Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients
Hepatitis C virus (HCV) is the major etiological agent of human non-A and non-B hepatitis, affecting around 180 million people worldwide. Defensins, small cysteine-rich cationic peptides, are shown to have potent antibacterial, antiviral, and antifungal properties. Defensins can be found in both nor...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2016/8373819 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558175743639552 |
|---|---|
| author | Ehab H. Mattar Hussein A. Almehdar Abdullah A. AlJaddawi Isam ElDin M. Abu Zeid Elrashdy M. Redwan |
| author_facet | Ehab H. Mattar Hussein A. Almehdar Abdullah A. AlJaddawi Isam ElDin M. Abu Zeid Elrashdy M. Redwan |
| author_sort | Ehab H. Mattar |
| collection | DOAJ |
| description | Hepatitis C virus (HCV) is the major etiological agent of human non-A and non-B hepatitis, affecting around 180 million people worldwide. Defensins, small cysteine-rich cationic peptides, are shown to have potent antibacterial, antiviral, and antifungal properties. Defensins can be found in both normal and microbial infected patients, at variable concentrations. Notably, viral infections are often associated with elevated concentrations of defensins. The current study aimed to estimate the concentrations of total, α-, and β-defensins in serum taken from normal and HCV-infected patients. 12 healthy (noninfected) and 34 HCV-infected patients were enrolled. Standardized immunoassay kits were used to obtain serum concentrations of defensins. The obtained results were calibrated against kit standard reagents. Total defensin concentrations in HCV-infected patients were significantly higher (2- to 105-fold) compared to healthy individuals. The concentrations of α-defensins were also significantly elevated in the HCV-infected patients (31–1398 ng/50 μL). However, concentrations of β-defensins ranged from 44.5 ng/50 μL to 1056 ng/50 μL. The results did not reveal differences in serum defensin concentration between male and female HCV-infected patients. A-defensin concentration of ≥250 ng/50 μL was found to contain more β-defensins than total defensins and α-defensins. This study concludes, for the first time, that serum defensin levels are elevated in HCV-infected patients. |
| format | Article |
| id | doaj-art-5a25b7344f5a4ba7af49ba99b46b8d3c |
| institution | Kabale University |
| issn | 2314-8861 2314-7156 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-5a25b7344f5a4ba7af49ba99b46b8d3c2025-02-03T01:32:56ZengWileyJournal of Immunology Research2314-88612314-71562016-01-01201610.1155/2016/83738198373819Elevated Concentration of Defensins in Hepatitis C Virus-Infected PatientsEhab H. Mattar0Hussein A. Almehdar1Abdullah A. AlJaddawi2Isam ElDin M. Abu Zeid3Elrashdy M. Redwan4Department of Biological Sciences, Faculty of Sciences, King Abdulaziz University, P.O. Box 80203, Jeddah, Saudi ArabiaDepartment of Biological Sciences, Faculty of Sciences, King Abdulaziz University, P.O. Box 80203, Jeddah, Saudi ArabiaDepartment of Biological Sciences, Faculty of Sciences, King Abdulaziz University, P.O. Box 80203, Jeddah, Saudi ArabiaDepartment of Biological Sciences, Faculty of Sciences, King Abdulaziz University, P.O. Box 80203, Jeddah, Saudi ArabiaDepartment of Biological Sciences, Faculty of Sciences, King Abdulaziz University, P.O. Box 80203, Jeddah, Saudi ArabiaHepatitis C virus (HCV) is the major etiological agent of human non-A and non-B hepatitis, affecting around 180 million people worldwide. Defensins, small cysteine-rich cationic peptides, are shown to have potent antibacterial, antiviral, and antifungal properties. Defensins can be found in both normal and microbial infected patients, at variable concentrations. Notably, viral infections are often associated with elevated concentrations of defensins. The current study aimed to estimate the concentrations of total, α-, and β-defensins in serum taken from normal and HCV-infected patients. 12 healthy (noninfected) and 34 HCV-infected patients were enrolled. Standardized immunoassay kits were used to obtain serum concentrations of defensins. The obtained results were calibrated against kit standard reagents. Total defensin concentrations in HCV-infected patients were significantly higher (2- to 105-fold) compared to healthy individuals. The concentrations of α-defensins were also significantly elevated in the HCV-infected patients (31–1398 ng/50 μL). However, concentrations of β-defensins ranged from 44.5 ng/50 μL to 1056 ng/50 μL. The results did not reveal differences in serum defensin concentration between male and female HCV-infected patients. A-defensin concentration of ≥250 ng/50 μL was found to contain more β-defensins than total defensins and α-defensins. This study concludes, for the first time, that serum defensin levels are elevated in HCV-infected patients.http://dx.doi.org/10.1155/2016/8373819 |
| spellingShingle | Ehab H. Mattar Hussein A. Almehdar Abdullah A. AlJaddawi Isam ElDin M. Abu Zeid Elrashdy M. Redwan Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients Journal of Immunology Research |
| title | Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients |
| title_full | Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients |
| title_fullStr | Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients |
| title_full_unstemmed | Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients |
| title_short | Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients |
| title_sort | elevated concentration of defensins in hepatitis c virus infected patients |
| url | http://dx.doi.org/10.1155/2016/8373819 |
| work_keys_str_mv | AT ehabhmattar elevatedconcentrationofdefensinsinhepatitiscvirusinfectedpatients AT husseinaalmehdar elevatedconcentrationofdefensinsinhepatitiscvirusinfectedpatients AT abdullahaaljaddawi elevatedconcentrationofdefensinsinhepatitiscvirusinfectedpatients AT isameldinmabuzeid elevatedconcentrationofdefensinsinhepatitiscvirusinfectedpatients AT elrashdymredwan elevatedconcentrationofdefensinsinhepatitiscvirusinfectedpatients |